Clinical Trial Update: Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections [Phase 4]

View source ↗

Summary

Phase 4 trial update for daptomycin in patients with renal insufficiency and soft tissue infections, including complicated skin and skin structure infections; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections
• Soft Tissue Infections

Drugs mentioned

• Daptomycin (Cubicin) (daptomycin)

Snippet

Sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Soft Tissue Infections | Phase 4 | Status: TERMINATED